Actarit

14,000,000 Leading Edge Experts on the ideXlab platform

Scan Science and Technology

Contact Leading Edge Experts & Companies

Scan Science and Technology

Contact Leading Edge Experts & Companies

The Experts below are selected from a list of 156 Experts worldwide ranked by ideXlab platform

Garreta Gambús I Albert - One of the best experts on this subject based on the ideXlab platform.

  • Cristal·lització de la lipoxigenasa de "Pseudomonas aeruginosa" 42A2 i estudi filogenètic de les subfamílies de les lipoxigenases (Tesi)
    'Edicions de la Universitat de Barcelona', 2010
    Co-Authors: Garreta Gambús I Albert
    Abstract:

    [cat] Les lipoxigenases són conegudes com les responsables de la catàlisi d'oxigenació molecular d’àcids grassos poli-insaturats que forma un producte hydroperoxid (tòxic) que es pot convertir en una gran varietat de metabòlits secundaris. Durant anys, la presència de lipoxgenases ha estat descrita únicament en organismes eucariotes, mamífers, plantes, petits invertebrats marins i fongs. La funció biològica de les lipoxigenases eucariotes ha estat àmpliament estudiada. Estan involucrades en la síntesi de molècules de senyalització com els leucotriens, en mamífers, o en la de l’àcid jasmònic, en plantes. L’any 1964, Shimahara, publicava la presència d’una lipoxigenasa en un bacteri gram-negatiu aïllat de les escombraries. Encara avui són poques les informacions referents a lipoxigenases bacterianes que s'han publicat, alguns exemples són les de Thermoactinomyces vulgaris, Pseudomonas i Nostoc punctiforme. Els anàlisis que s’han realitzat utilitzant el programa BLAST, indiquen que hi ha gens “LOX-like” en Shewanella, Burkolderia, Nitrosomonas i Myxococcus, però la funció biològica de lipoxigenases procariotes encara no s'ha aclarit. No obstant, les lipoxigenases publicades en la base de dades “gene data-bank” són d’organismes ambientals de medi marí i de sòls, això suggereix que les lipoxigenases poden tenir un paper important en la biodegradació. En aquest estudi es reporta la primera estructura molecular d'una lipoxigenasa procariota i un estudi preliminar de la filogènia d’aquest grup de proteïnes.[eng] The lipoxygenases are known as responsible for the reaction of oxygenation of poly-unsaturated fatty acid producing hydroperoxid acids (toxic) that can be converted into a different secondary metabolites. For years, the presence of lipoxygenases has been described only in eukaryotes, mammals, plants, fungi and small invertebrates. The biological function of eukaryotic lipoxygenases has been widely studied. They are involved in the synthesis of leukotrienes as signaling molecules in mammals, or in the jasmonic acid in plants. In 1964, Shimahara, published the existence of lipoxygenases of gram-negative bacteria isolated from the trash. Even today there are few data concerning bacterial lipoxygenases published. Some examples are those of Thermoactinomyces vulgaris, Pseudomonas and Nostoc punctiforme. The analysis were performed using the BLAST program and the results indicate that there are "LOX-like" genes in Shewanella, Burkolderia, Nitrosomonas and Myxococcus, but the biological function of prokaryotic lipoxygenases is not yet clear. However, lipoxygenases published in the database "gene data-bank" are marine organisms and environmental grounds, suggesting that the lipoxygenases can play an important role in biodegradation. This study reports the first molecular structure of a prokaryotic lipoxygenasa and a preliminary study of the phylogeny of this group of proteins

  • Cristal•lització de la lipoxigenasa de "Pseudomonas aeruginosa" 42A2 i estudi filogenètic de les subfamílies de les lipoxigenases
    'Edicions de la Universitat de Barcelona', 2010
    Co-Authors: Garreta Gambús I Albert
    Abstract:

    Les lipoxigenases són conegudes com les responsables de la catàlisi d'oxigenació molecular d’àcids grassos poli-insaturats que forma un producte hydroperoxid (tòxic) que es pot convertir en una gran varietat de metabòlits secundaris. Durant anys, la presència de lipoxgenases ha estat descrita únicament en organismes eucariotes, mamífers, plantes, petits invertebrats marins i fongs. La funció biològica de les lipoxigenases eucariotes ha estat àmpliament estudiada. Estan involucrades en la síntesi de molècules de senyalització com els leucotriens, en mamífers, o en la de l’àcid jasmònic, en plantes. L’any 1964, Shimahara, publicava la presència d’una lipoxigenasa en un bacteri gram-negatiu aïllat de les escombraries. Encara avui són poques les informacions referents a lipoxigenases bacterianes que s'han publicat, alguns exemples són les de Thermoactinomyces vulgaris, Pseudomonas i Nostoc punctiforme. Els anàlisis que s’han realitzat utilitzant el programa BLAST, indiquen que hi ha gens “LOX-like” en Shewanella, Burkolderia, Nitrosomonas i Myxococcus, però la funció biològica de lipoxigenases procariotes encara no s'ha aclarit. No obstant, les lipoxigenases publicades en la base de dades “gene data-bank” són d’organismes ambientals de medi marí i de sòls, això suggereix que les lipoxigenases poden tenir un paper important en la biodegradació. En aquest estudi es reporta la primera estructura molecular d'una lipoxigenasa procariota i un estudi preliminar de la filogènia d’aquest grup de proteïnes.The lipoxygenases are known as responsible for the reaction of oxygenation of poly-unsaturated fatty acid producing hydroperoxid acids (toxic) that can be converted into a different secondary metabolites. For years, the presence of lipoxygenases has been described only in eukaryotes, mammals, plants, fungi and small invertebrates. The biological function of eukaryotic lipoxygenases has been widely studied. They are involved in the synthesis of leukotrienes as signaling molecules in mammals, or in the jasmonic acid in plants. In 1964, Shimahara, published the existence of lipoxygenases of gram-negative bacteria isolated from the trash. Even today there are few data concerning bacterial lipoxygenases published. Some examples are those of Thermoactinomyces vulgaris, Pseudomonas and Nostoc punctiforme. The analysis were performed using the BLAST program and the results indicate that there are "LOX-like" genes in Shewanella, Burkolderia, Nitrosomonas and Myxococcus, but the biological function of prokaryotic lipoxygenases is not yet clear. However, lipoxygenases published in the database "gene data-bank" are marine organisms and environmental grounds, suggesting that the lipoxygenases can play an important role in biodegradation. This study reports the first molecular structure of a prokaryotic lipoxygenasa and a preliminary study of the phylogeny of this group of proteins

Rabi Sankar Bhatta - One of the best experts on this subject based on the ideXlab platform.

  • a liquid chromatography tandem mass spectrometry method for the quantitation of Actarit in rabbit plasma application to pharmacokinetics and metabolic stability
    Journal of Mass Spectrometry, 2016
    Co-Authors: Rachumallu Ramakrishna, Manisha Bhateria, Santosh Kumar Puttrevu, Yarra Durga Prasad, Rajbir Singh, Rabi Sankar Bhatta
    Abstract:

    Actarit (ATR), 4-acetylaminophenylacetic acid is an orally effective disease-modifying anti-rheumatic drug widely prescribed for the treatment of rheumatoid arthritis. The present study demonstrates the first report on a selective and sensitive liquid chromatography-tandem mass spectrometry method for the quantification of ATR in rabbit plasma using p-coumaric acid as an internal standard (IS). Following liquid-liquid extraction, chromatographic separation of the reconstituted samples was achieved isocratically on a Syncronis-C18 column with a mobile phase consisting of aqueous ammonium acetate (10 mM, pH 4)- methanol and acetonitrile mixture (8 : 92, v/v) at a flow rate of 0.6 ml/min. ATR and IS were detected using electrospray ionization operated in negative multiple reaction monitoring mode. The calibration curve was linear (r(2)  ≥ 0.990) over the concentration range of 1-4000 ng/ml with a lower limit of quantitation of 1 ng/ml. The mean extraction recovery of ATR and IS from rabbit plasma was greater than 85%. The method complied well with US Food and Drug Administration guidelines for selectivity, sensitivity, accuracy, precision, matrix effect, dilution integrity, carry-over effect and stability. The method was successfully applied to in vitro metabolic stability (using rabbit liver microsomes) and in vivo pharmacokinetic study after oral administration of ATR at a dose of 10 mg/kg in New Zealand rabbits. Copyright © 2015 John Wiley & Sons, Ltd.

Kamala K. Vasu - One of the best experts on this subject based on the ideXlab platform.

  • Stability-indicating assay method for determination of Actarit, its process related impurities and degradation products: Insight into stability profile and degradation pathways
    Journal of Pharmaceutical Analysis, 2014
    Co-Authors: A. Abiramasundari, Rahul P. Joshi, Hitesh B. Jalani, Jayesh A. Sharma, Amit N. Pandya, D.h. Pandya, V. Sudarsanam, Kamala K. Vasu
    Abstract:

    The stability of the drug Actarit was studied under different stress conditions like hydrolysis (acid, alkaline and neutral), oxidation, photolysis and thermal degradation as recommended by International Conference on Harmonization (ICH) guidelines. Drug was found to be unstable in acidic, basic and photolytic conditions and produced a common degradation product while oxidative stress condition produced three additional degradation products. Drug was impassive to neutral hydrolysis, dry thermal and accelerated stability conditions. Degradation products were identified, isolated and characterized by different spectroscopic analyses. Drug and the degradation products were synthesized by a new route using green chemistry. The chromatographic separation of the drug and its impurities was achieved in a phenomenex luna C18 column employing a step gradient elution by high performance liquid chromatography coupled to photodiode array and mass spectrometry detectors (HPLC-PDA-MS). A specific and sensitive stability-indicating assay method for the simultaneous determination of the drug Actarit, its process related impurities and degradation products was developed and validated.

  • Stability-indicating assay method for determination of Actarit, its process related impurities and degradation products: Insight into stability profile and degradation pathwaysâ
    Elsevier, 2014
    Co-Authors: A. Abiramasundari, Rahul P. Joshi, Hitesh B. Jalani, Jayesh A. Sharma, Amit N. Pandya, D.h. Pandya, V. Sudarsanam, Kamala K. Vasu
    Abstract:

    The stability of the drug Actarit was studied under different stress conditions like hydrolysis (acid, alkaline and neutral), oxidation, photolysis and thermal degradation as recommended by International Conference on Harmonization (ICH) guidelines. Drug was found to be unstable in acidic, basic and photolytic conditions and produced a common degradation product while oxidative stress condition produced three additional degradation products. Drug was impassive to neutral hydrolysis, dry thermal and accelerated stability conditions. Degradation products were identified, isolated and characterized by different spectroscopic analyses. Drug and the degradation products were synthesized by a new route using green chemistry. The chromatographic separation of the drug and its impurities was achieved in a phenomenex luna C18 column employing a step gradient elution by high performance liquid chromatography coupled to photodiode array and mass spectrometry detectors (HPLCâPDAâMS). A specific and sensitive stability-indicating assay method for the simultaneous determination of the drug Actarit, its process related impurities and degradation products was developed and validated. Keywords: Actarit, Forced degradation, Stability-indicating assay metho

Rachumallu Ramakrishna - One of the best experts on this subject based on the ideXlab platform.

  • a liquid chromatography tandem mass spectrometry method for the quantitation of Actarit in rabbit plasma application to pharmacokinetics and metabolic stability
    Journal of Mass Spectrometry, 2016
    Co-Authors: Rachumallu Ramakrishna, Manisha Bhateria, Santosh Kumar Puttrevu, Yarra Durga Prasad, Rajbir Singh, Rabi Sankar Bhatta
    Abstract:

    Actarit (ATR), 4-acetylaminophenylacetic acid is an orally effective disease-modifying anti-rheumatic drug widely prescribed for the treatment of rheumatoid arthritis. The present study demonstrates the first report on a selective and sensitive liquid chromatography-tandem mass spectrometry method for the quantification of ATR in rabbit plasma using p-coumaric acid as an internal standard (IS). Following liquid-liquid extraction, chromatographic separation of the reconstituted samples was achieved isocratically on a Syncronis-C18 column with a mobile phase consisting of aqueous ammonium acetate (10 mM, pH 4)- methanol and acetonitrile mixture (8 : 92, v/v) at a flow rate of 0.6 ml/min. ATR and IS were detected using electrospray ionization operated in negative multiple reaction monitoring mode. The calibration curve was linear (r(2)  ≥ 0.990) over the concentration range of 1-4000 ng/ml with a lower limit of quantitation of 1 ng/ml. The mean extraction recovery of ATR and IS from rabbit plasma was greater than 85%. The method complied well with US Food and Drug Administration guidelines for selectivity, sensitivity, accuracy, precision, matrix effect, dilution integrity, carry-over effect and stability. The method was successfully applied to in vitro metabolic stability (using rabbit liver microsomes) and in vivo pharmacokinetic study after oral administration of ATR at a dose of 10 mg/kg in New Zealand rabbits. Copyright © 2015 John Wiley & Sons, Ltd.

A. Abiramasundari - One of the best experts on this subject based on the ideXlab platform.

  • Stability-indicating assay method for determination of Actarit, its process related impurities and degradation products: Insight into stability profile and degradation pathways
    Journal of Pharmaceutical Analysis, 2014
    Co-Authors: A. Abiramasundari, Rahul P. Joshi, Hitesh B. Jalani, Jayesh A. Sharma, Amit N. Pandya, D.h. Pandya, V. Sudarsanam, Kamala K. Vasu
    Abstract:

    The stability of the drug Actarit was studied under different stress conditions like hydrolysis (acid, alkaline and neutral), oxidation, photolysis and thermal degradation as recommended by International Conference on Harmonization (ICH) guidelines. Drug was found to be unstable in acidic, basic and photolytic conditions and produced a common degradation product while oxidative stress condition produced three additional degradation products. Drug was impassive to neutral hydrolysis, dry thermal and accelerated stability conditions. Degradation products were identified, isolated and characterized by different spectroscopic analyses. Drug and the degradation products were synthesized by a new route using green chemistry. The chromatographic separation of the drug and its impurities was achieved in a phenomenex luna C18 column employing a step gradient elution by high performance liquid chromatography coupled to photodiode array and mass spectrometry detectors (HPLC-PDA-MS). A specific and sensitive stability-indicating assay method for the simultaneous determination of the drug Actarit, its process related impurities and degradation products was developed and validated.

  • Stability-indicating assay method for determination of Actarit, its process related impurities and degradation products: Insight into stability profile and degradation pathwaysâ
    Elsevier, 2014
    Co-Authors: A. Abiramasundari, Rahul P. Joshi, Hitesh B. Jalani, Jayesh A. Sharma, Amit N. Pandya, D.h. Pandya, V. Sudarsanam, Kamala K. Vasu
    Abstract:

    The stability of the drug Actarit was studied under different stress conditions like hydrolysis (acid, alkaline and neutral), oxidation, photolysis and thermal degradation as recommended by International Conference on Harmonization (ICH) guidelines. Drug was found to be unstable in acidic, basic and photolytic conditions and produced a common degradation product while oxidative stress condition produced three additional degradation products. Drug was impassive to neutral hydrolysis, dry thermal and accelerated stability conditions. Degradation products were identified, isolated and characterized by different spectroscopic analyses. Drug and the degradation products were synthesized by a new route using green chemistry. The chromatographic separation of the drug and its impurities was achieved in a phenomenex luna C18 column employing a step gradient elution by high performance liquid chromatography coupled to photodiode array and mass spectrometry detectors (HPLCâPDAâMS). A specific and sensitive stability-indicating assay method for the simultaneous determination of the drug Actarit, its process related impurities and degradation products was developed and validated. Keywords: Actarit, Forced degradation, Stability-indicating assay metho